Professional Documents
Culture Documents
Bacterial Meningitis HSV Encephalitis: Therapeutic Guidelines Antibiotic
Bacterial Meningitis HSV Encephalitis: Therapeutic Guidelines Antibiotic
Bacterial Meningitis HSV Encephalitis: Therapeutic Guidelines Antibiotic
Bacterial
meningitis
HSV
encephalitis
URINARY
Acute cystitis
Acute
pyelonephritis
GASTROINTESTINAL
Cholecystitis
Cholangitis
Peritonitis due
to perforation
Cellulitis
Assess exposure
risk for gram
negative organisms
(and seek expert
advice)
This guideline must not replace clinical judgement. May not apply to immunocompromised
patients
Detailed guidelines available via CIAP on intranet: Therapeutic Guidelines Antibiotic v 14, 2010.
Check local antibiotic restriction policies
1
RESPIRATORY
Communityacquired
pneumonia
(CAP)
Mild CAP
Amoxycillin 1g orally every 8 hours for 5 to 7 days OR
Doxycycline orally, 200mg for 1st dose, then 100mg daily for 5 days
Moderate CAP (requiring admission)
Hospitalacquired
pneumonia
(HAP)
HAP in high-risk
wards for 5 days or
longer (e.g. ICU,
high-dependency
units, known specific
resistance problem)
Infective
exacerbation of
COPD
Reassess the need for IV antibiotic administration in your patient when they are
tolerating oral intake, have no absorption problems and show clinical improvement.
For oral formulations or suitable alternatives check with ward pharmacist.
Oral therapy is NOT suitable for initial treatment of endocarditis, meningitis, osteomyelitis,
septic arthritis or Staph. aureus bacteraemia where a high tissue antibiotic concentration is
required.
DAILY REVIEW OF ANTIBIOTIC MANAGEMENT FOR CONSIDERATION OF RATIONALISATION
AND DE-ESCALATION IS REQURIED.
This card has been produced by the Area Antimicrobial Stewardship Committee, Clinical Governance
Unit, SESIAHS. http://sesiweb.lan.sesahs.nsw.gov.au/clinical%20Governance%20unit/default.asp
Expires Jan 2013